HSP90AA1 and neoplasm: Based on the previous research of high-frequency mutations USP8 in corticotropinoma, this study tended to explore the regulation of the EGFR pathway by HSP90 involved in the pathogenesis of the tumor, discover potential treatment for Cushing’s disease, and provide evidence for precise treatment.